Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

NCT00804050 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

184

Enrollment

OTHER

Sponsor class

Stopped Difficulties of enrollment

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: infusion A: rEPO
DRUG: B Infusion rEPO combined with vitamins pills

Sponsor

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Collaborators

[object Object]